Get the Stockscreener App
1.405
2.77%
-0.045
Mustang Bio Inc stock is traded at $1.405, with a volume of 23,553.
It is down -2.77% in the last 24 hours and down -10.77% over the past month.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$1.45
Open:
$1.45
24h Volume:
23,553
Relative Volume:
0.19
Market Cap:
$8.96M
Revenue:
-
Net Income/Loss:
$-23.42M
P/E Ratio:
-0.018
EPS:
-78
Net Cash Flow:
$-16.67M
1W Performance:
-6.01%
1M Performance:
-10.77%
6M Performance:
+29.34%
1Y Performance:
-89.44%
1-Day Range:
$1.40
$1.45
1-Week Range:
$1.40
$1.52
52-Week Range:
$0.8926
$21.95
Mustang Bio Inc Stock (MBIO) Company Profile
Name
Mustang Bio Inc
Sector
Industry
Phone
(781) 652-4500
Address
377 PLANTATION STREET, WORCESTER, NY
Compare MBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
1.402 | 10.50M | 0 | -23.42M | -16.67M | -78.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.72 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.12 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Oct-02-20 | Initiated | B. Riley FBR | Buy |
| Nov-20-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-19 | Initiated | H.C. Wainwright | Buy |
| Jun-21-19 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-21-17 | Initiated | Oppenheimer | Outperform |
View All
Mustang Bio Inc Stock (MBIO) Latest News
Is Mustang Bio Inc. stock affected by interest rate hikes2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
Detecting price anomalies in Mustang Bio Inc. with AIJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
Will Mustang Bio Inc. stock benefit from upcoming earnings reportsWeekly Trend Recap & Free Risk Controlled Daily Trade Plans - newser.com
Will Mustang Bio Inc. price bounce be sustainableJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
How strong is Mustang Bio Inc. stock balance sheetWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com
How Mustang Bio Inc. stock compares to growth peersQuarterly Investment Review & Low Volatility Stock Suggestions - newser.com
How sustainable is Mustang Bio Inc. stock dividend payoutPortfolio Performance Report & Fast Entry High Yield Tips - newser.com
What analysts say about Mustang Bio Inc stockGeopolitical Risk Analysis & High Return Portfolio Growth - earlytimes.in
Can Mustang Bio Inc. stock deliver strong Q4 earnings2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
News impact scoring models applied to Mustang Bio Inc.Market Performance Report & Real-Time Market Sentiment Alerts - newser.com
Is Mustang Bio Inc. still worth holding after the dipGap Down & Weekly Watchlist for Hot Stocks - newser.com
Is Mustang Bio Inc. stock a safe investment in uncertain markets2025 Price Action Summary & Verified Technical Signals - newser.com
Smart tools for monitoring Mustang Bio Inc.’s price actionMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
Is Mustang Bio Inc a good long term investmentAnalyst Upgrades & Consistent Triple Returns - earlytimes.in
Identifying reversal signals in Mustang Bio Inc.July 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
How institutional buying supports Mustang Bio Inc. stockJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com
Mustang Bio Inc Stock (MBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):